AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
16min chapter
Can a ‘miracle’ weight loss drug end Britain's obesity epidemic? [Replay]
The Story
Revolutionizing Diabetes: From Treatment to Weight Loss
This chapter explores the groundbreaking developments in diabetes treatments, particularly focusing on semaglutide, a synthetic hormone derived from lizard saliva. It examines the societal implications of its unexpected side effect of weight loss, notably its adoption by celebrities, and discusses the rising popularity of Novo Nordisk's drugs, Ozempic and Wegovy, in managing obesity. Through the lens of personal narratives and the company’s history, the chapter delves into the transformation of pharmaceutical approaches to weight management and diabetes care.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode